Rhamnocitrin

2 Cited Publications
Avis client

Based on 2 publication(s) in Google Scholar

Rhamnocitrin is an anti-inflammatory and antioxidant agent that targets STIM-1, NFATc3 and MAPK pathways and can scavenge DPPH (IC50=28.38 mM). Rhamnocitrin selectively inhibits oxidative stress and inflammatory responses in vascular endothelial cells and neurons. Rhamnocitrin up-regulates miR-185 to inhibit STIM-1-mediated store-operated calcium entry (SOCE), thereby blocking NFATc3 nuclear translocation and downstream inflammatory factor expression, while inducing heme oxygenase HO-1 expression and regulating the ERK/p38 MAPK pathway, inhibiting antioxidant and pro-inflammatory cytokines (such as IL-6, IL-8) and adhesion molecules (such as ICAM-1, VCAM-1). Rhamnocitrin can be used in the study of endothelial-related inflammatory diseases (such as sepsis, acute lung injury, atherosclerosis) and neuroprotection (such as oxidative damage of PC12 cells).

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • Pureté: 99.29%
  • CAS No.: 569-92-6
  • Formule: C16H12O6
  • Masse moléculaire:300.26
  • Stockage:

    4°C, protect from light

    * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

  • Activité biologique
  • Chemical Information
  • Solvant et solubilité
  • Pureté et documentation
  • Références
  • Help & FAQs
You May Still Need

Publications Citing Use of MedChemExpress (MCE) Rhamnocitrin

More
Customer Validation & Images
Cell Proliferation/Viability AssayIFFlow CytometryWB
  • Cell Proliferation/Viability Assay
  • IF
  • Flow Cytometry
  • WB

Voir tous les produits spécifiques à Isoform p38 MAPK

More
100 mg

Obtenir un devis En stock

Please select quantity
Amount: USD 0.00